The geographic footprint of the EZH2 Inhibitors Market is expanding far beyond its traditional strongholds in North America and Western Europe. As healthcare infrastructure improves in the Asia-Pacific and Latin American regions, the demand for advanced oncology treatments is rising sharply. In group discussions, it is important to analyze how the EZH2 Inhibitors Market region dynamics are...